News FDA fast-tracks Lilly/Pfizer pain drug amid opioid crisis Companies hope tanezumab offers alternative to opioids
News FDA makes unprecedented move, asks Endo to pull painkiller f... Regulator concerned about potential abuse of Opana ER
News FDA to review Novartis CAR-T next month If all goes well, FDA could approve CTL109 by late September
News Safety restrictions spell the end for Servier osteoporosis d... Sales of Protelos hit by safety restrictions.
News FDA approves first ALS treatment for two decades FDA asked Mitsubishi to file Radicava following approval in Japan.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
